Sign in
4

Changes in Ownership

Adicet Bio, Inc. Filed Acc 0000899243-19-013558

Options or other derivatives

  • Chief Scientific Officer acquired 295,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Klickstein Lloyd · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-05-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +295,000 $8.08 2029-05-12 295,000 295,000 D
Loading xslF345X03/doc4.xml…